Loeppky R N, Bae J Y
Department of Chemistry, University of Missouri, Columbia 65211.
Chem Res Toxicol. 1994 Nov-Dec;7(6):861-7. doi: 10.1021/tx00042a022.
The nitrosation chemistry of 1,3,5-trimethyl-5-aminohexahydropyrimidine (2) has been investigated as a model for the behavior of the antimicrobial agent hexetidine (1) under similar conditions. The reaction of 2 with sodium nitrite in glacial acetic acid gives 4-methyl-4-[(methylnitrosamino)methyl]-3-nitroso-1,3-oxazolidine (4) as the major nitrosamine. This compound arises from a molecular rearrangement which proceeds through the diazotization of the primary amino group followed by intramolecular displacement of nitrogen to generate an aziridinium ion. The N-nitrosooxazolidine 4 forms from the nitrosation of an imidazolidine produced from the aziridinium ring hydrolytic opening. The N-nitrosooxazolidine 4, an isomer, 5-methyl-5-[(methylnitrosamino)methyl]-3-nitroso-1,3-oxazolidine (14), which is not formed in the nitrosation of 2, and an analog 4-methyl-4-[[(2-ethylhexyl)nitrosamino]methyl]-3-nitroso-1,3-oxazolidine (22) have been independently synthesized. The N-nitrosooxazolidine 22 which would be formed from hexetidine is not present in its nitrosation mixture, suggesting the absence of reactive aziridinium ions in that case. The dissimilar nitrosation chemistry of 2 and 1 are discussed.
已对1,3,5-三甲基-5-氨基六氢嘧啶(2)的亚硝化反应进行了研究,以此作为抗菌剂己脒定(1)在类似条件下行为的模型。2与亚硝酸钠在冰醋酸中的反应生成4-甲基-4-[(甲基亚硝基氨基)甲基]-3-亚硝基-1,3-恶唑烷(4)作为主要亚硝胺。该化合物源于分子重排,其过程是伯氨基重氮化,然后氮进行分子内取代生成氮杂环丙烷离子。N-亚硝基恶唑烷4由氮杂环丙烷环水解开环产生的咪唑烷亚硝化形成。已独立合成了异构体5-甲基-5-[(甲基亚硝基氨基)甲基]-3-亚硝基-1,3-恶唑烷(14)以及类似物4-甲基-4-[[(2-乙基己基)亚硝基氨基]甲基]-3-亚硝基-1,3-恶唑烷(22),它们在2的亚硝化反应中未形成。己脒定亚硝化混合物中不存在由己脒定形成的N-亚硝基恶唑烷22,这表明在该情况下不存在反应性氮杂环丙烷离子。讨论了2和1不同的亚硝化反应。